Cargando…

Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations

Oleuropein (OE) is a secoiridoid glycoside, which occurs mostly in the Oleaceae family presenting several pharmacological properties, including antioxidant, cardio-protective, anti-atherogenic effects etc. Based on these findings OE is commercially available, as Herbal Medicinal Product (HMP), claim...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemonakis, Nikolaos, Gikas, Evagelos, Halabalaki, Maria, Skaltsounis, Alexios-Leandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804515/
https://www.ncbi.nlm.nih.gov/pubmed/24205178
http://dx.doi.org/10.1371/journal.pone.0078277
_version_ 1782288161507901440
author Lemonakis, Nikolaos
Gikas, Evagelos
Halabalaki, Maria
Skaltsounis, Alexios-Leandros
author_facet Lemonakis, Nikolaos
Gikas, Evagelos
Halabalaki, Maria
Skaltsounis, Alexios-Leandros
author_sort Lemonakis, Nikolaos
collection PubMed
description Oleuropein (OE) is a secoiridoid glycoside, which occurs mostly in the Oleaceae family presenting several pharmacological properties, including antioxidant, cardio-protective, anti-atherogenic effects etc. Based on these findings OE is commercially available, as Herbal Medicinal Product (HMP), claimed for its antioxidant effects. As there are general provisions of the medicine regulating bodies e.g. European Medicines Agency, the quality of the HMP’s must always be demonstrated. Therefore, a novel LC-MS methodology was developed and validated for the simultaneous quantification of OE and its main degradation product, hydroxytyrosol (HT), for the relevant OE claimed HMP’s. The internal standard (IS) methodology was employed and separation of OE, HT and IS was achieved on a C18 Fused Core column with 3.1 min overall run time employing the SIM method for the analytical signal acquisition. The method was validated according to the International Conference on Harmonisation requirements and the results show adequate linearity (r(2) > 0.99) over a wide concentration range [0.1–15 μg/mL (n=12)] and a LLOQ value of 0.1 μg/mL, for both OE and HT. Furthermore, as it would be beneficial to control the quality taking into account all the substances of the OE claimed HMP’s; a metabolomics-like approach has been developed and applied for the total quality control of the different preparations employing UHPLC-HRMS-multivariate analysis (MVA). Four OE-claimed commercial HMP’s have been randomly selected and MVA similarity-based measurements were performed. The results showed that the examined samples could also be differentiated as evidenced according to their scores plot. Batch to batch reproducibility between the samples of the same brand has also been determined and found to be acceptable. Overall, the developed combined methodology has been found to be an efficient tool for the monitoring of the HMP’s total quality. Only one OE HMP has been found to be consistent to its label claim.
format Online
Article
Text
id pubmed-3804515
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38045152013-11-07 Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations Lemonakis, Nikolaos Gikas, Evagelos Halabalaki, Maria Skaltsounis, Alexios-Leandros PLoS One Research Article Oleuropein (OE) is a secoiridoid glycoside, which occurs mostly in the Oleaceae family presenting several pharmacological properties, including antioxidant, cardio-protective, anti-atherogenic effects etc. Based on these findings OE is commercially available, as Herbal Medicinal Product (HMP), claimed for its antioxidant effects. As there are general provisions of the medicine regulating bodies e.g. European Medicines Agency, the quality of the HMP’s must always be demonstrated. Therefore, a novel LC-MS methodology was developed and validated for the simultaneous quantification of OE and its main degradation product, hydroxytyrosol (HT), for the relevant OE claimed HMP’s. The internal standard (IS) methodology was employed and separation of OE, HT and IS was achieved on a C18 Fused Core column with 3.1 min overall run time employing the SIM method for the analytical signal acquisition. The method was validated according to the International Conference on Harmonisation requirements and the results show adequate linearity (r(2) > 0.99) over a wide concentration range [0.1–15 μg/mL (n=12)] and a LLOQ value of 0.1 μg/mL, for both OE and HT. Furthermore, as it would be beneficial to control the quality taking into account all the substances of the OE claimed HMP’s; a metabolomics-like approach has been developed and applied for the total quality control of the different preparations employing UHPLC-HRMS-multivariate analysis (MVA). Four OE-claimed commercial HMP’s have been randomly selected and MVA similarity-based measurements were performed. The results showed that the examined samples could also be differentiated as evidenced according to their scores plot. Batch to batch reproducibility between the samples of the same brand has also been determined and found to be acceptable. Overall, the developed combined methodology has been found to be an efficient tool for the monitoring of the HMP’s total quality. Only one OE HMP has been found to be consistent to its label claim. Public Library of Science 2013-10-21 /pmc/articles/PMC3804515/ /pubmed/24205178 http://dx.doi.org/10.1371/journal.pone.0078277 Text en © 2013 Lemonakis et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lemonakis, Nikolaos
Gikas, Evagelos
Halabalaki, Maria
Skaltsounis, Alexios-Leandros
Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title_full Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title_fullStr Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title_full_unstemmed Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title_short Development and Validation of a Combined Methodology for Assessing the Total Quality Control of Herbal Medicinal Products – Application to Oleuropein Preparations
title_sort development and validation of a combined methodology for assessing the total quality control of herbal medicinal products – application to oleuropein preparations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804515/
https://www.ncbi.nlm.nih.gov/pubmed/24205178
http://dx.doi.org/10.1371/journal.pone.0078277
work_keys_str_mv AT lemonakisnikolaos developmentandvalidationofacombinedmethodologyforassessingthetotalqualitycontrolofherbalmedicinalproductsapplicationtooleuropeinpreparations
AT gikasevagelos developmentandvalidationofacombinedmethodologyforassessingthetotalqualitycontrolofherbalmedicinalproductsapplicationtooleuropeinpreparations
AT halabalakimaria developmentandvalidationofacombinedmethodologyforassessingthetotalqualitycontrolofherbalmedicinalproductsapplicationtooleuropeinpreparations
AT skaltsounisalexiosleandros developmentandvalidationofacombinedmethodologyforassessingthetotalqualitycontrolofherbalmedicinalproductsapplicationtooleuropeinpreparations